在心脏手术后的功能性三腹吐和死亡率之间的关联
Timothy C Tan1, Louis Mullie2, Aidan W Flynn1
1Cardiac Ultrasound Laboratory, Division of Cardiology, Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA.
JACC. Advances
|June 28, 2024
概括
在心脏手术患者中,中度的功能性三回 (TR) 与较高的死亡率和发病率有关,特别是没有肺高血压. 这一发现影响了非严重TR的外科修复指南.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 心声回声图 (Echocardiography) 是一种心声回声图.
背景情况:
- 目前的指导方针建议在心脏手术期间修复一些非严重的三腹吐 (TR).
- 对于TR的预后意义和术后结果仍然不清楚.
研究的目的:
- 评估功能性TR在各种心脏手术中的预后影响.
- 为了确定改变与TR相关的风险的患者特征.
主要方法:
- 包括接受冠状动脉旁路,大动脉和 mitra 门手术的患者.
- 排除了严重的TR,有机三门疾病,三门手术或缺乏最近的心声图.
- 利用来自胸腔外科医生协会成人心脏手术数据库和外部验证队列的数据.
主要成果:
- 中度TR (9%) 独立地与中期死亡率 (HR:2.58) 和住院死亡率或主要发病率 (OR:3.18) 的增加有关.
- 这种关联在肺动脉静脉压<40毫米升 (P=0.036) 的患者中是显著的.
结论:
- 适度的功能TR独立地预测了当代心脏手术患者的较差结果.
- 死亡和发病率的风险增加在没有肺高血压的患者中尤其明显.
相关概念视频
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


